key: cord-0252249-t6sp1to1 authors: Khan, Adil I.; Khan, Mazeeya; Tirimacco, Rosy title: Catering for the Point-of-Care Testing Explosion date: 2021-06-29 journal: EJIFCC DOI: nan sha: 4332335f5fe1981823e017470a437e02379da2cf doc_id: 252249 cord_uid: t6sp1to1 The ease of performing a laboratory test near to the patient, at the point-of-care, has resulted in the integration of point-of-care tests into healthcare treatment algorithms. However, their importance in patient care necessitates regular oversight and enforcement of best laboratory practices. This review discusses why this oversight is needed, it’s importance in ensuring quality results and processes that can be placed to ensure point-of-care tests are chosen carefully so that both oversight can be maintained and patient care is improved. Furthermore, it highlights the importance of delivering focused webinars and continuing education in a variety of formats. The ease of performing a laboratory test near to the patient, at the point-of-care, has resulted in the integration of point-of-care tests into healthcare treatment algorithms. However, their importance in patient care necessitates regular oversight and enforcement of best laboratory practices. This review discusses why this oversight is needed, it's importance in ensuring quality results and processes that can be placed to ensure point-of-care tests are chosen carefully so that both oversight can be maintained and patient care is improved. Furthermore, it highlights the importance of delivering focused webinars and continuing education in a variety of formats. Point-of-care diagnostics has grown at an unprecedented rate. The convenience of being able to test yourself or a patient by a small, portable point-of-care device, that is easy to use, requires very little trouble shooting and provides results within a matter of seconds to minutes has fueled the explosion in point-of-care testing instruments world-wide, enabling them to find a key role in managing patient health. Furthermore, the current COVID-19 pandemic has illustrated, more so to the general public at large, the importance of having a process in place for efficient diagnosis and triaging of patients for disease management [1] . However good POC technologies are, there is a need for governments with help from national societies to develop strategies for effective implementation [2] . A recent survey conducted by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Point-of-Care Testing (IFCC C-POCT) ( Figure 1 ) showed that 62% of member societies did not have an official pointof-care testing committee ( Figure 2A ) and in 55% of member countries, point-of-care testing was performed without any formal regulation ( Figure 2B ). This data show that whilst pointof-care testing has become an important part of patient testing and diagnostic algorithms, it is still being performed in a significant number of countries without official hospital and regulatory oversight. This does not necessarily mean that it is being done incorrectly, however being performed in a non-standardized way, without official oversight does open up that possibility. This is important because having a POC testing committee and standardized POC testing guidelines mandated nationally leads to accountability in the management of POC testing. Moreover, these numbers gathered by the IFCC C-POCT, are actually an underestimation since only a very small number of countries represented South America, Africa, Asia and the Middle East ( Figure 1 ). Performing POC testing in a non-standardized manner, without any official quality assurance program that includes performance improvement indicators, and regular audits, makes the POC testing program vulnerable to potential errors in the pre-analytical, analytical and post analytical stages and thus hinders potential benefits it can provide in patient management through the system. Simply following the manufacturer's instructions is not always sufficient to ensure quality results. Employing regulatory guidelines that have been developed through collaboration amongst experts within the field with a "best laboratory practices" mindset, using clinical and industry quality benchmarks, in addition to manufacturer recommendations is important. For example, in 2016, a hospital in the United States found two patients with hepatitis C infections due to unsafe practices in a hemodialysis unit. Further investigation showed that there was a lack of compliance to infection control processes such as failure to change gloves when staff moved between equipment or using ungloved hands without proper hand hygiene. Lack of cleaning and disinfection of environmental surfaces (visible bloodstains on dialysis machine, on dialysis station televisions, and on patient chairs) [3] . The instruments being used for PT/INR patients are also potential sources of infection. In another United States study [4] , nurse staff demonstrated a lack of infection control and best practices, despite training and competency in the use of the instruments. The staff were also not educated on the type of disinfectant to use, and the contact time for the disinfectant to remain wet on the surface of the prothrombin monitoring device [4] . Depending on the manufacturer, the package insert does not always fully address good laboratory practices. For example, when using glucose meters, the vendor may not always mention in their package inserts that glucose meters needs to be disinfected when used between different patients. In a multicenter study of glucose meter usage in 12 hospitals in the United States, that were classified as urban, suburban, or rural, 30.2% ± 17.5% of the glucose meters studied had blood contamination, and the incidence was 2 times higher in the intensive care units. The number of operators per unit also correlated with higher incidences of blood contamination [5, 6] , and another U.S. study found that hepatitis B infection outbreaks were increased in long-term care facilities [7, 8] . These examples highlight the importance of education associated with POC testing that goes beyond the package insert and regulation in the form of standardized policies that addresses the three phases of testing, in addition to regular audits and most importantly accountability corrective actions for deficiencies. An important feature of POC testing that sets it apart from other healthcare disciplines is that the users can come from a wide variety of backgrounds, including, nurses, nurse aids, respiratory care practitioners, perfusionists, physicians, paramedics and other healthcare workers ( Figure 3 ). As a result, training has to be geared to address the different educational backgrounds, often with no previous laboratory experience and a lack of familiarity with concepts such as quality control, quality assurance and root cause analysis [9] . Consequently, there is a requirement to have a robust POC testing program headed at a minimum by a director or equivalent to initiate institutional change and a POC coordinator that can implement the change [9] . The POC coordinator is the key to any successful POC testing program and is often a clinical laboratory professionals since they have both laboratory experience and knowledge. People-skills are equally important because they are constantly communicating to POC test users and involved in their training and education [10] . In the United States, the Clinical Laboratory Improvements Amendments of 1988 (CLIA'88) regulate laboratory testing through three federal agencies: the Food and Drug Administration (FDA), Center for Medicaid Services (CMS) and the Center for Disease Control (CDC). Each agency has a unique role in assuring quality in laboratory testing (See Table 1 .) The FDA categorizes tests according to their level of complexity [11] . There are three categories: waived, moderate complexity, and high complexity. A test that is classified as "waived" is simple to use, and will not cause harm to the patient if done incorrectly. Generally, overthe-counter and at-home use tests are given this category. The next classification, moderate and high complexity tests (also known as nonwaived testing) is determined by the FDA committee, after reviewing the package insert and making the assessment based on 7 categories, with each being given a score of 1, 2, or 3. The lowest level of complexity is given a score of "1" and "3" to the highest level of complexity. When the 7 scores are added together if the sum is 12 or below it is a moderate complexity test and if above 12, a high complexity test. See Table 2 , showing how FDA determines whether a test is categorized as moderate or high complexity and grades it accordingly by giving it a score of 1-3 [11]. In the United States, point-of-care tests used in hospitals usually belong to either waived or moderately complex category. This categorization can be effective in limiting the adoption of a POC tests in a hospital because each category is associated with different regulations, in terms of quality assurance practices, such as frequency of quality control, linearity, calibration, instrument correlations. For waived tests, manufacturer's instructions need to be followed, however, moderately complex tests in addition require linearities to be performed if applicable, instrument correlations, enrollment Table 2 Showing Categorization criteria • Score 1. (A) Minimal scientific and technical knowledge is required to perform the test; and (B) Knowledge required to perform the test may be obtained through on-the-job instruction. • Score 3. Specialized scientific and technical knowledge is essential to perform pre-analytic, analytic or post-analytic phases of the testing. • Score 1. (A) Minimal training is required for pre-analytic, analytic and post-analytic phases of the testing process; and (B) Limited experience is required to perform the test. • Score 3. (A) Specialized training is essential to perform the pre-analytic, analytic or postanalytic testing process; or Substantial experience may be necessary for analytic test performance. • Score 1. (A) Reagents and materials are generally stable and reliable; and (B) Reagents and materials are prepackaged, or premeasured, or require no special handling, precautions or storage conditions. • Score 3. (A) Reagents and materials may be labile and may require special handling to assure reliability; or (B) Reagents and materials preparation may include manual steps such as gravimetric or volumetric measurements. • Score 1. Operational steps are either automatically executed (such as pipetting, temperature monitoring, or timing of steps), or are easily controlled. • Score 3. Operational steps in the testing process require close monitoring or control, and may require special specimen preparation, precise temperature control or timing of procedural steps, accurate pipetting, or extensive calculations. • Score 3. (A) Calibration materials, if available, may be labile; (B) Quality control materials may be labile, or not available; or (C) External proficiency testing materials, if available, may be labile. • • Score 1. (A) Test system troubleshooting is automatic or self-correcting, or clearly described or requires minimal judgment; and (B) Equipment maintenance is provided by the manufacturer, is seldom needed, or can easily be performed. • Score 3. (A) Troubleshooting is not automatic and requires decision-making and direct intervention to resolve most problems; or (B) Maintenance requires special knowledge, skills, and abilities. • Score 1. (A) Minimal interpretation and judgment are required to perform pre-analytic, analytic and post-analytic processes; and (B) Resolution of problems requires limited independent interpretation and judgment. • Score 3. (A) Extensive independent interpretation and judgment are required to perform the pre-analytic, analytic or post-analytic processes; and (B) Resolution of problems requires extensive interpretation and judgment. There are three sections of an IQCP [13]: (1) Risk assessment: The purpose is to map the testing process so to identify procedural weaknesses. At a minimum it is made up of 5 components: This monitors the quality control plan to determine of the processes that have been put in place to reduce the weaknesses in the testing processes are effective and evaluates, but is not limited to the following: i. QC reviews ii. PT performance reviews iii. Chart reviews Webinars form an essential communication tool that has been increasingly used due to the social restrictions imposed by the COVID-19 pandemic. Their effectiveness can be seen in figure 5A -C which breaks down some of the data gathered from a recent Asia Pacific Point-of-Care Webinar on "The Role of Blood Gas in Overall Management of COVID-19 Patients." Point-of-care testing will become increasingly intertwined with how healthcare systems manage acute and chronic diseases. Furthermore, a lack of reliance on healthcare infrastructure in resource limited settings makes POCT devices an attractive alternative to centralized laboratory testing [14] . Best laboratory practices are essential for meaningful results as is their appropriate use. However, the point-of-care diagnostics explosion outpaces global regulatory oversight that is needed in this sector and confirms the need to meet this demand with focused webinars, educational and practical workshops to ensure best laboratory practices are followed. Transforming Clinical Pathways Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks Rosy Tirimacco Catering for the point-of-care testing explosion A Large Outbreak of Hepatitis C Virus Infections in a Hemodialysis Clinic Cleaning and Disinfecting Prothrombin Monitoring Equipment. Home Healthc Now PhD Multicenter Study of the Prevalence of Blood Contamination on Point-of-Care Glucose Meters and Recommendations for Controlling Contamination PhD Using Glucose Meters in Hospital Environments: Some Challenges and Resolutions for Point-of-Care Testing Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies An outbreak of hepatitis B in an endocrinology unit traced to a capillary-blood-sampling device Quality Requirements for Point of Care Testing when Traditional Systems Fail Clinical and Laboratory Standards Institute. Laboratory Quality Control Based on Risk Management Point-of-Care Diagnostics in Low Resource Settings: Present Status and Future Role of Microfluidics. Biosensors